Unlock rapid, cost‑effective hormone‑therapy research with our premium Aromasin (Exemestane)-25mg tablets. Designed for pharmaceutical manufacturers, CROs, and research institutions, this API delivers consistent 99.8% purity, GMP‑certified production, and high‑speed delivery to the USA and other English‑speaking markets.
When you’re managing a portfolio of hormone‑therapy projects, every delay or cost overrun directly erodes your ROI. Below are the three most common pain points you encounter with low‑quality or poorly‑managed suppliers.
According to a 2025 industry survey, 37% of procurement managers cite “unreliable delivery” as the top reason for switching suppliers. If you’re still wrestling with these issues, your product pipeline is at risk.
Our Aromasin (Exemestane)-25mg is manufactured in a **state‑of‑the‑art, GMP‑compliant facility** that integrates **DMF‑approved** processes, **ISO 9001**, and **FDA‑registered** quality systems. Below are the core advantages that directly address the pain points outlined above.
| Parameter | Specification |
|---|---|
| Active Ingredient | Exemestane (Aromasin) |
| Strength | 25 mg per tablet |
| Purity | ≥ 99.8% (HPLC) |
| Appearance | White, round, film‑coated tablet |
| Shelf Life | 36 months (store < 25 °C, dry) |
| Packaging Options | HDPE bottles, blister packs, bulk drums (up to 500 kg) |
| Regulatory Certifications | GMP, ISO 9001, FDA‑registered, DMF, CE, RoHS |
Case Study 1 – Rapid Oncology Trial Launch (USA)
A leading biotech firm needed 50 kg of Exemestane for a Phase II breast‑cancer trial. Our fast‑track service delivered the entire order within 7 days from purchase order, cutting their projected timeline by 3 weeks and saving $12,000 in freight.
Case Study 2 – Cost‑Effective Generic Production (Europe)
A European generic manufacturer switched to our Aromasin (Exemestane)-25mg and realized a 28% reduction in raw‑material cost while maintaining regulatory compliance, enabling a market‑entry price advantage of €0.15 per tablet.
3-3'-diethylthiadicarbocyanine-iodide Annonacin ADAM21 ABBV-151
Our client portfolio includes multinational pharmaceutical companies, CROs, and research universities. Below is a snapshot of our most recognizable partners.
Client Logo Wall (textual representation)
Pfizer | Novartis | Bristol‑Myers Squibb | GSK | Eli Lilly | Merck | Amgen | AstraZeneca | Roche | Johnson & Johnson
Customer Testimonials
Certifications & Compliance
Q1: What is the minimum order quantity (MOQ) for Aromasin (Exemestane)-25mg?
A: Our standard MOQ is 1 kg (≈40,000 tablets). For exploratory research, we can supply 100 g with a fast‑track sample service.
Q2: Can you provide a custom tablet coating or dosage form?
A: Yes. Our OEM/ODM team can develop tablet coatings (e.g., enteric, film‑coat) and alternative dosage forms (powder, capsules) per your specifications.

Q3: How do you ensure batch‑to‑batch consistency?
A: Each batch undergoes full analytical testing (HPLC, MS, NMR, IR). Results are uploaded to a secure portal for real‑time client access.
Q4: What are the shipping options and associated costs to the USA?
A: We offer DHL Express (3‑5 days, $1,200 per 500 kg), FedEx Air (4‑6 days, $1,350), and sea freight (30‑45 days, $800 per container). All shipments are customs‑cleared with HS Code 2935.20.
Q5: Do you support regulatory filing assistance?
A: Our regulatory affairs team can provide DMF documentation, GMP certificates, and stability data packages to support IND, NDA, or ANDA submissions.
Q6: What after‑sales service is available?
A: 24/7 technical support, free re‑analysis of any batch within 30 days, and a dedicated account manager for order tracking.
Q7: Is there a money‑back guarantee if the product does not meet specifications?
A: Absolutely. If any analytical result falls below the agreed specification, we will replace the batch at no extra cost.
Only 500 kg of stock remaining at our promotional price. Secure your supply within the next 48 hours and receive:
Ready to lock in your competitive advantage?
Or contact us directly:
Dr. Lin Wei – Senior API Development Engineer with 15 years of experience in steroid synthesis, GMP compliance, and international regulatory affairs. Previously led the Exemestane production line at a top‑10 Chinese pharmaceutical group and now heads the Global Technology R&D division.
Published in Journal of Pharmaceutical Sciences (2024) on “Optimizing Steroid API Purity for Clinical Scale‑Up”. Holds a Ph.D. in Organic Chemistry (University of Zhengzhou) and is a certified ISO 9001 Lead Auditor.
For any technical queries, Dr. Lin can be reached at service@huanqiukeji9.com or via the contact details listed above.